| scholarly article | Q13442814 |
| P50 | author | Stefan Pöhlmann | Q37063445 |
| Andrea Marzi | Q50285805 | ||
| P2093 | author name string | Anja Wegele | |
| P2860 | cites work | Involvement of Clathrin-Mediated Endocytosis in Human Immunodeficiency Virus Type 1 Entry | Q22242226 |
| How Viruses Enter Animal Cells | Q22299358 | ||
| Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters | Q24315645 | ||
| A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family | Q24337205 | ||
| C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans | Q24537682 | ||
| Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR | Q24541155 | ||
| Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution | Q27617533 | ||
| Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain | Q27766228 | ||
| Development of a preventive vaccine for Ebola virus infection in primates | Q28140401 | ||
| The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination? | Q28201093 | ||
| HIV-1 infection and chemokine receptor modulation | Q28253623 | ||
| A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury | Q28260798 | ||
| Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus | Q28576023 | ||
| Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection | Q28588877 | ||
| Regulated portals of entry into the cell | Q29547391 | ||
| Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes | Q29619514 | ||
| Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein | Q30439990 | ||
| Ebola virus can be effectively neutralized by antibody produced in natural human infection | Q30712477 | ||
| Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses | Q30995893 | ||
| Comprehensive analysis of ebola virus GP1 in viral entry | Q33724185 | ||
| Mechanism of interference mediated by human parainfluenza virus type 3 infection | Q33812881 | ||
| Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus | Q33984296 | ||
| Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses | Q33987611 | ||
| Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates | Q34220503 | ||
| Ebola virus: from discovery to vaccine | Q34230491 | ||
| Association of the caveola vesicular system with cellular entry by filoviruses | Q34338277 | ||
| Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains | Q34395745 | ||
| Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses | Q34439347 | ||
| Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence | Q34969474 | ||
| Virus entry: molecular mechanisms and biomedical applications | Q35712985 | ||
| Role of CD4 receptor down-regulation during HIV-1 infection | Q35724962 | ||
| Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells | Q35843339 | ||
| Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions | Q35895035 | ||
| Filovirus budding | Q35965283 | ||
| Processing of the Ebola virus glycoprotein by the proprotein convertase furin | Q36098653 | ||
| Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry | Q36509382 | ||
| Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. | Q36642730 | ||
| A system for functional analysis of Ebola virus glycoprotein | Q36831630 | ||
| The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil | Q37377729 | ||
| The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing | Q37662967 | ||
| Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway | Q37746622 | ||
| LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus | Q38323040 | ||
| Glycosylation and oligomerization of the spike protein of Marburg virus | Q38335344 | ||
| Functional importance of the coiled-coil of the Ebola virus glycoprotein | Q39539619 | ||
| Envelope protein-mediated down-regulation of hepatitis B virus receptor in infected hepatocytes | Q39554543 | ||
| Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. | Q40163481 | ||
| The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. | Q40267837 | ||
| Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus | Q40354958 | ||
| Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. | Q40367288 | ||
| Enhancement of enveloped virus entry by phosphatidylserine. | Q40384538 | ||
| Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells. | Q40468565 | ||
| Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection | Q40504322 | ||
| How Ebola virus infects cells | Q40505469 | ||
| Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity | Q40546009 | ||
| DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. | Q40568477 | ||
| Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity | Q40606709 | ||
| Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. | Q40610887 | ||
| Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses | Q40616449 | ||
| Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury | Q40616926 | ||
| Epitopes involved in antibody-mediated protection from Ebola virus | Q40625468 | ||
| Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils | Q40627978 | ||
| Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins | Q40641586 | ||
| GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases | Q40676410 | ||
| The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus | Q40688834 | ||
| Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein | Q40703843 | ||
| Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus | Q40713530 | ||
| The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses | Q40731425 | ||
| Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. | Q41548414 | ||
| The pH independence of mammalian retrovirus infection | Q41738977 | ||
| Caveola-dependent endocytic entry of amphotropic murine leukemia virus | Q42811793 | ||
| Entry pathway of vesicular stomatitis virus into different host cells | Q42992016 | ||
| Interactions of a vesicular stomatitis virus G protein fragment with phosphatidylserine: NMR and fluorescence studies | Q44435732 | ||
| Neutralized vesicular stomatitis virus binds to host cells by a different “receptor” | Q45797983 | ||
| Receptor interference mediated by the envelope glycoproteins of various HIV-1 and HIV-2 isolates | Q46433796 | ||
| Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site? | Q54502841 | ||
| Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV | Q70310627 | ||
| Mutational analysis of HIV-1 gp160-mediated receptor interference: intracellular complex formation | Q71140242 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virion | Q1757347 |
| P304 | page(s) | 345-356 | |
| P577 | publication date | 2006-06-13 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization | |
| P478 | volume | 352 |
| Q90749594 | Analysis of Resistance of Ebola Virus Glycoprotein-Driven Entry Against MDL28170, An Inhibitor of Cysteine Cathepsins |
| Q40042137 | Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR. |
| Q64359849 | Calu-3 cells are largely resistant to entry driven by filovirus glycoproteins and the entry defect can be rescued by directed expression of DC-SIGN or cathepsin L |
| Q35589926 | Chemical and Structural Aspects of Ebola Virus Entry Inhibitors |
| Q35184639 | Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine |
| Q37051613 | Estimating the stoichiometry of human immunodeficiency virus entry |
| Q38123988 | Filovirus entry |
| Q35878069 | Filovirus entry into cells - new insights |
| Q37999360 | Filovirus entry: a novelty in the viral fusion world |
| Q36446078 | Generation of biologically contained Ebola viruses |
| Q38076136 | Host cell factors in filovirus entry: novel players, new insights |
| Q64056996 | Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins |
| Q37448307 | The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies |
| Q45323651 | The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells. |
| Q40039066 | The lifecycle of the Ebola virus in host cells |
Search more.